Compare Crispr Therapeutics AG (CRSP) vs Dolby Laboratories, Inc. (DLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Dolby Laboratories, Inc. — how do they compare? Crispr Therapeutics AG trades at $53.9 (market cap $5.23B), while Dolby Laboratories, Inc. trades at $60.91 (market cap $5.75B). The key difference: Crispr Therapeutics AG and Dolby Laboratories, Inc. are close in size by market cap, and Dolby Laboratories, Inc. pays a 2.35% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | DLB | |
|---|---|---|
Market Cap | $5.23B | $5.75B |
Sector | Health | Industrials |
52-Week High | $76.78 | $75.62 |
52-Week Low | $44.34 | $48.51 |
Enterprise Value | $3.65B | $5.12B |
Dividend Yield | — | 2.35% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Dolby Laboratories, Inc.
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →
